Biotech Investors & VC Firms in North America
1593 firms in this list, with a median first check of $500K. 347 of them lead rounds. Generated from verified public data and updated continuously.
StarChain Ventures
Silicon ValleyPre-Seed–Series B
2 people
Swift Street Capital
DurhamSeed–Series A
2 people
The Broad Foundations
Los Angeles
2 people
Voltage Ventures
PortlandPre-Seed–Seed
2 people
Brain Trust Accelerator Fund
BurlingameSeed–Series A
1 person
Walder Ventures
Chicago
1 person
FundRx
Palo AltoPre-Seed–Seed
IMPACT SCIENCE VENTURES
Palo Alto
3 people
Olive Capital
AthertonSeed
Fjord Ventures
Laguna HillsSeed–Series A
1 person
Matthew Brown
NewarkSeed
1 person
MCMA Ventures, LLC
DenverPre-Seed–Seed
1 person
Perseverance Capital
Los Angeles
1 person
ward.ventures
Prairie VillageGrowth
1 person
Y Innovations
CambridgeSeed–Series B
1 person
Bioverge
San FranciscoSeed
5 people
CIBC
TorontoPre-Seed–Late Stage$1.5M – $29.2M
2 people
1004 Venture Partners
San DiegoPre-Seed–Seed
1 person
Boxer Capital, LLC
San DiegoSeed–Late Stage
1 person
Cresswell Advisors
TorontoSeed–Series A
1 person
Biomark Capital
GreenwichSeries A–Late Stage$5M – $10M
4 people
Precision Health Informatics
DallasSeed
7 people
Shea Ventures, LLC
WalnutSeed–Series A
4 people
SymBiosis
BentonvilleSeed–Late Stage
4 people
Related lists
Investors & VC Firms in North America (13518)Investors & VC Firms in United States (12555)Investors & VC Firms in Europe (5846)Investors & VC Firms in Global (4720)AI & Machine Learning Investors & VC Firms (4549)Fintech Investors & VC Firms (4537)SaaS Investors & VC Firms (4215)Healthtech Investors & VC Firms (4185)Enterprise Software Investors & VC Firms (4097)Crypto & Web3 Investors & VC Firms (3965)
Data sourced from public filings and firms' own websites — see our methodology.




























